Paclitaxel Pliva

Paclitaxel, the active ingredient in Paclitaxel Pliva, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours and is administered under the supervision of oncologists in hospital settings.

GNH USA supplies Paclitaxel Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Paclitaxel is an antineoplastic drug that interferes with cell growth across a range of solid tumours. - Breast cancer: Improves the treatment outcome by reducing tumour size and delaying progression. - Ovarian cancer: Used as first‑line therapy in combination with carb‑c​ ​ ​ ​  . - Non‑small cell NSCLC :   t    g  \,  . -  \\  . -  t  t  -  . -  . -  t """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

...